


Ask a doctor about a prescription for CINITAPRIDE NORMON 1mg TABLETS
Package Leaflet: Information for the User
Cinitaprida Normon 1 mg Tablets EFG
Cinitaprida
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Cinitaprida belongs to a group of medicines called prokinetics, which work by stimulating gastrointestinal motility.
Cinitaprida is indicated for the treatment of gastroesophageal reflux to enhance the effect of proton pump inhibitors (medicines that reduce gastric acid production) and mild to moderate functional disorders of gastrointestinal motility.
Consult your doctor or pharmacist before taking cinitaprida if you are an elderly patient and take the medicine for a prolonged period, as it may cause tardive dyskinesia (rapid and repetitive movements of the head, neck, trunk, or limbs that may appear months after treatment has been discontinued).
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Cinitaprida may increase the neurological effects of some medicines, especially those used to treat diseases of the nervous system, for insomnia, and for relief of moderate or severe pain.
Cinitaprida may decrease the effect of digoxin, a medicine used to treat heart failure.
On the other hand, some medicines may decrease the action of cinitaprida. In the case of some medicines used to treat Parkinson's disease, abdominal pain, or respiratory diseases such as chronic bronchitis.
Cinitaprida should not be taken with alcohol, as it enhances its sedative effects.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy:
There are no data on the use of cinitaprida in pregnant women. Animal studies do not suggest direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of cinitaprida during pregnancy.
Your doctor will decide whether you should take cinitaprida or not.
Breastfeeding:
It is unknown whether the medicine is excreted in breast milk. As a precautionary measure, it is preferable to avoid the use of this medicine during breastfeeding.
Do not drive or operate hazardous machinery during treatment with cinitaprida.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Remember to take your medicine.
Use in adults (over 20 years old)
The recommended dose for adults (over 20 years old) is 1 tablet, 3 times a day, 15 minutes before each meal.
It is not more effective, nor convenient to increase the recommended doses.
Your doctor will indicate the duration of your treatment with cinitaprida. Do not stop the treatment before.
The tablets should be taken orally with a glass of water.
If you think the action of cinitaprida is too strong or too weak, tell your doctor or pharmacist.
Use in children and adolescents
Administration of cinitaprida is not recommended in children and adolescents due to lack of experience in these age groups.
The score line should not be used to divide the tablet.
If you take more Cinitaprida Normon than you should
If you have taken more cinitaprida than you should, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 915 620 420, indicating the medicine and the amount taken.
Symptoms of overdose may be: drowsiness, disorientation, and extrapyramidal reactions (involuntary muscle movements of the face, neck, and tongue) that normally disappear when treatment is discontinued.
If you forget to take Cinitaprida Normon
Do not take a double dose to make up for forgotten doses. Take the forgotten dose when you remember and then follow your regular schedule. However, if it is almost time for your next dose, do not take the forgotten dose and wait for the next dose at the scheduled time.
If you stop treatment with Cinitaprida Normon
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Cinitaprida Normon can cause side effects, although not everybody gets them.
Side effects may be:
Uncommon (may affect up to 1 in 100 people)
Some patients may notice mild sedation or drowsiness.
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store below 30°C.
Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Cinitaprida Normon
The active substance is cinitaprida (as hydrogen tartrate). Each tablet contains 1 mg of cinitaprida.
The other ingredients (excipients) are: lactose, microcrystalline cellulose, sodium carboxymethyl starch (type A) (potato), colloidal silica, and magnesium stearate.
Appearance of the product and contents of the pack
Cinitaprida Normon 1 mg is presented in the form of tablets. They are yellow, round, biconvex tablets with a score line on one side. Each pack contains 50 tablets.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of last revision of this package leaflet:June 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CINITAPRIDE NORMON 1mg TABLETS in November, 2025 is around 6.73 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CINITAPRIDE NORMON 1mg TABLETS – subject to medical assessment and local rules.